A polypill that includes key medications associated with improved outcomes (aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as a simple approach to the secondary ...
The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient. The PROFID EHRA trial is part of ...
A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...
In a recent study published in the journal Nature Cardiovascular Research, researchers developed and validated a novel biomarker-based prediction model to evaluate imminent first myocardial infarction ...
Dr Ray O’Connor looks at the latest clinical studies on therapeutics, including beta-lockers and potassium sparing diuretics ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Myocardial ischemia, also called cardiac ischemia, is a condition characterized by reduced blood flow to the heart. A common cause is plaque buildup in the coronary arteries. Myocardial ischemia may ...
Long-term oral Beta-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new myocardial infarction, or heart failure by 25% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results